NCT02506517 2023-08-01A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER GeneUniversity Health Network, TorontoPhase 2 Completed12 enrolled
NCT05107193 2022-11-08Afatinib (GILOTRIF®) in Patients Suffering From Tumors Harboring Neuregulin 1 (NRG1) Gene Alterations (Specifically NRG1 Gene Fusion-positive Advanced Solid Tumors)Boehringer IngelheimNo longer available